Briefly, tumor cell-derived factors (e.g., parathyroid hormone-related protein (PTHrP) and interleukin 11 (IL-11)) alter the RANKL/OPG ratio in favor of osteoclast activity [21,22]. Here, IL11 is linked to neoplasm.